Nucala 40 mg (Mepolizumab SOLUTION) 40 MG

NUCALA 40 MG is a subcutaneous solution containing mepolizumab, used for managing specific inflammatory conditions. This medication is designed to help control symptoms and improve quality of life.

Strength

40 MG

Manufacturer / TM Owner

GLAXOSMITHKLINE INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

NUCALA 40 MG is primarily used for the treatment of severe eosinophilic asthma in adults and children aged 6 years and older. It works by reducing the number of eosinophils, a type of white blood cell, in the blood. This medication is also used for other conditions characterized by high eosinophil counts, such as eosinophilic granulomatosis with polyangiitis (EGPA). Patients often wonder, 'What is NUCALA used for?' and the answer lies in its ability to target and reduce inflammation caused by eosinophils.

Side Effects

Common effects of NUCALA 40 MG may include reactions at the injection site, such as redness, swelling, or itching. Some users may experience headaches, joint pain, or fatigue. These effects are generally mild and temporary. It's important to monitor for any persistent or severe reactions and consult a healthcare provider if necessary.

Precautions & Warnings

NUCALA 40 MG should be administered under the supervision of a healthcare professional. It is crucial to follow proper storage and handling instructions to maintain the medication's efficacy. Patients with a history of allergic reactions to mepolizumab or any of the ingredients should avoid using this medication. Always inform your healthcare provider about any existing medical conditions or medications you are taking.

Avoid Interactions

NUCALA 40 MG may interact with other medications, including those that affect the immune system. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol and certain foods may also affect how the body responds to this medication. Always consult a healthcare professional for personalized advice.

Frequently Asked Questions

NUCALA 40 MG is used to treat severe eosinophilic asthma and other conditions characterized by high eosinophil counts, such as eosinophilic granulomatosis with polyangiitis (EGPA).

NUCALA 40 MG is administered as a subcutaneous injection, typically by a healthcare professional.

Common side effects may include reactions at the injection site, headaches, joint pain, and fatigue.

Yes, NUCALA 40 MG is approved for use in children aged 6 years and older for the treatment of severe eosinophilic asthma.

NUCALA 40 MG should be stored in the refrigerator between 2°C to 8°C (36°F to 46°F) and protected from light.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.